Overall there are 18 potential awards for two years each. There are 4 awards in prevention and translational lung cancer research that are jointly sponsored with the Prevent Cancer Foundation (PCF), through educational grants from Eli Lilly (3), and Bristol-Myers Squibb (1). There are 14 unrestricted awards in any field of lung cancer research supported by educational grants from National Lung Cancer Partnership (1), GlaxoSmithKline (3), Sanofi-Aventis (3), AstraZeneca (3), Celgene (1), Pfizer (1), Eli Lilly (1), and OSI (1).

This year 8 new unrestricted awards of $40,000 each year for 2 years are available for competition.

We are now requesting application for these Fellowships and Young Investigator awards to be awarded in 2008. The goal is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. The applications will be evaluated by a Scientific Review Panel; the deadline for submission of the application is January 15, 2008. A decision on applications will be reached by March 2008.

Application forms can be found at the website: www.iaslc.org

Please e-mail you application to: pia.Hirsch@uchsc.edu latest January 15, 2008